ImaginAb, Inc. Innovative Biologics Technology platform acquired by Telix to enable Next-Generation Therapeutic Assets discovery
ImaginAb, Inc., announces that it has entered into an agreement to sell a pipeline of next-generation therapeutic candidates, ...
Stifel maintains buy on Carnival stock, price target at $34
Stifel analysts maintained their Buy rating on Carnival Corporation (NYSE:CCL) shares, with a steady price target of $34.00. According to InvestingPro data, 12 analysts have recently revised their ...
3 Biotech Stocks With Notable Insider Buying
Despite a 15% drop in the SPDR S&P Biotech ETF, insider buying presents opportunities. Read why these small and mid-cap ...
Hold Rating Given for Zanzalintinib Based on STELLAR-001 Trial Outcomes
Stifel Nicolaus analyst Stephen Willey has maintained their neutral stance on EXEL stock, giving a Hold rating today.Invest with Confidence: ...
Annex Advisory Services LLC Purchases New Position in Royal Caribbean Cruises Ltd. (NYSE:RCL)
Annex Advisory Services LLC purchased a new stake in shares of Royal Caribbean Cruises Ltd. (NYSE:RCL – Free Report) during ...
C.H. Robinson Worldwide (CHRW) Expected to Announce Earnings on Wednesday
C.H. Robinson Worldwide (NASDAQ:CHRW – Get Free Report) is expected to post its quarterly earnings results after the market ...
Cautious Hold Rating for Edgewise Therapeutics Amid Uncertain Differentiation and Efficacy
Paul Matteis, an analyst from Stifel Nicolaus, has initiated a new Hold rating on Edgewise Therapeutics (EWTX).Invest with Confidence: Follow ...
Disc Medicine Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Inc. (NASDAQ: IRON) (Disc), a clinical-stage biopharmaceutical company focused on the discovery, development, and ...
Stifel maintains Buy on Evolus, price target steady at $25
Stifel analysts maintained a Buy rating on Evolus (NASDAQ:EOLS) with a steady price target of $25.00. The firm's positive ...